Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors (NCT07287917)
OrganizationBiotech
Aminex Therapeutics, Inc.
Organization linked by public source evidence.
Public IDs
No public external ID is attached.
Related people
No reviewed person affiliation is attached.
Outputs
No reviewed output is linked through affiliated people.
Topics
Relationship evidence
Timeline
No dated relationship evidence is attached.